Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: DCB001
MIFTS: 45

Decubitus Ulcer

Categories: Skin diseases
Genes Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Decubitus Ulcer

About this section

MalaCards integrated aliases for Decubitus Ulcer:

Name: Decubitus Ulcer 12 15
Pressure Ulcer 12 55 44 15 73
Pressure Sores 12 43
Decubitus Ulcer, Lower Back 12
Decubitus Ulcer, Other Site 12
Decubitus Ulcer, Upper Back 12
Decubitus Ulcer Any Site 12
Decubitus Ulcer, Elbow 12
Decubitus Ulcer 12
Pressure Ulcers 63
Bedsore 12

Classifications:

MalaCards categories:
Anatomical: Skin diseases
See all MalaCards categories (disease lists)
ICD10: 33


External Ids:

Disease Ontology 12 DOID:8717
ICD10 33 L89 L89.9
ICD9CM 35 707.0 707.00
MeSH 44 D003668
NCIt 50 C50706
SNOMED-CT 68 28103007 90144002
UMLS 73 C0011127
Sources

Summaries for Decubitus Ulcer

About this section
MedlinePlus : 43 Pressure sores are areas of damaged skin caused by staying in one position for too long. They commonly form where your bones are close to your skin, such as your ankles, back, elbows, heels and hips. You are at risk if you are bedridden, use a wheelchair, or are unable to change your position. Pressure sores can cause serious infections, some of which are life-threatening. They can be a problem for people in nursing homes. You can prevent the sores by Keeping skin clean and dry Changing position every two hours Using pillows and products that relieve pressure Pressure sores have a variety of treatments. Advanced sores are slow to heal, so early treatment is best.

MalaCards based summary : Decubitus Ulcer, also known as pressure ulcer, is related to nutritional deficiency disease and acute cystitis, and has symptoms including pruritus and exanthema. An important gene associated with Decubitus Ulcer is TTR (Transthyretin), and among its related pathways/superpathways is FOXA2 and FOXA3 transcription factor networks. The drugs acetic acid and Nitric Oxide have been mentioned in the context of this disorder. Affiliated tissues include skin, spinal cord and bone.

Disease Ontology : 12 Decubitus ulcer is a chronic ulcer of skin where the ulcer is an ulceration of tissue deprived of adequate blood supply by prolonged pressure.

PubMed Health : 63 About pressure ulcers: Some people inevitably spend a lot of time in a sitting or lying position. Most of them keep moving and shifting a little, consciously or subconsciously. But people who are extremely weak, paralyzed or unconscious may sit or lie motionless in the same position for a very long time. This puts them at greater risk of developing pressure ulcers (also called bedsores or pressure sores), which are open wounds caused by persistent external pressure against the skin. They can be very painful and usually take a long time to heal.

Wikipedia : 76 Pressure ulcers, also known as pressure sores, decubitus ulcers, and bedsores, and now referred to as... more...

Sources

Related Diseases for Decubitus Ulcer

About this section

Diseases related to Decubitus Ulcer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 129)
# Related Disease Score Top Affiliating Genes
1 nutritional deficiency disease 30.3 ALB CRP TTR
2 acute cystitis 30.0 ALB CRP
3 intermittent claudication 29.9 ALB CRP
4 bacterial meningitis 29.9 ALB CRP
5 myeloma, multiple 29.9 ALB CRP FGF2
6 endocarditis 29.7 ALB CRP
7 burns 29.7 CRP TTR
8 chronic ulcer of skin 29.4 ALB BSN COPS2 FGF2 SETD2 TTR
9 vascular disease 29.4 ALB CRP FGF2
10 ulcer of lower limbs 11.2
11 paramyloidosis 10.2 ALB TTR
12 marasmus 10.2 ALB TTR
13 kwashiorkor 10.2 ALB TTR
14 aleutian mink disease 10.2 ALB TTR
15 thyroid crisis 10.2 ALB TTR
16 hyperthyroxinemia 10.2 ALB TTR
17 blind loop syndrome 10.2 ALB TTR
18 diffuse glomerulonephritis 10.2 ALB FGF2
19 autonomic nervous system disease 10.2 ALB TTR
20 protein-energy malnutrition 10.2 ALB TTR
21 demyelinating polyneuropathy 10.2 ALB TTR
22 testicular yolk sac tumor 10.2 ALB TTR
23 gastrointestinal tuberculosis 10.2 ALB CRP
24 abdominal tuberculosis 10.1 ALB CRP
25 pyuria 10.1 ALB CRP
26 amyloidosis aa 10.1 CRP TTR
27 spinal cord injury 10.1
28 tuberculous peritonitis 10.1 ALB CRP
29 pericardium disease 10.1 ALB CRP
30 hypersensitivity reaction type iii disease 10.1 ALB CRP
31 peptic ulcer perforation 10.1 ALB CRP
32 prediabetes syndrome 10.1 ALB CRP
33 diverticulitis 10.1 CRP FGF2
34 acute pyelonephritis 10.1 ALB CRP
35 pyelonephritis 10.1 ALB CRP
36 proctitis 10.1 CRP FGF2
37 pleural disease 10.1 ALB CRP
38 hemorrhagic fever with renal syndrome 10.1 ALB CRP
39 heart conduction disease 10.1 CRP TTR
40 pericardial effusion 10.1 CRP FGF2
41 interstitial nephritis 10.1 ALB CRP
42 appendicitis 10.1 ALB CRP
43 typhoid fever 10.1 ALB CRP
44 coronary stenosis 10.1 ALB CRP
45 squamous cell carcinoma 10.1
46 meningitis 10.1
47 analbuminemia 10.1 ALB CRP TTR
48 dysentery 10.1 ALB CRP TTR
49 obstructive jaundice 10.0 ALB CRP TTR
50 acquired metabolic disease 10.0 ALB CRP TTR

Comorbidity relations with Decubitus Ulcer via Phenotypic Disease Network (PDN): (show top 50) (show all 109)


Acquired Thrombocytopenia Active Peptic Ulcer Disease
Acute Conjunctivitis Acute Cystitis
Acute Kidney Failure Acute Myocardial Infarction
Acute Vascular Insufficiency of Intestine Alzheimer Disease
Aortic Valve Disease 1 Bacteremia 2
Bronchitis Bronchopneumonia
Bullous Pemphigoid Candidiasis
Cardiac Arrest Cerebral Atherosclerosis
Cerebral Degeneration Cerebrovascular Disease
Chronic Kidney Failure Chronic Myocardial Ischemia
Chronic Ulcer of Skin Communicating Hydrocephalus
Conjunctivitis Cystitis
Deficiency Anemia Dermatomycosis
Diabetes Mellitus, Ketosis-Prone Diabetes Mellitus, Noninsulin-Dependent
Diabetic Polyneuropathy Disseminated Intravascular Coagulation
Encephalopathy Epilepsy, Focal, with Speech Disorder and with or Without Mental Retardation
Erythematosquamous Dermatosis Esophageal Candidiasis
Esophageal Disease Familial Atrial Fibrillation
Fecal Incontinence Femoral Vein Thrombophlebitis
Folic Acid Deficiency Anemia Gas Gangrene
Generalized Atherosclerosis Heart Disease
Hepatic Encephalopathy Hydronephrosis
Hypertension, Essential Hyperuricemia, Pulmonary Hypertension, Renal Failure, and Alkalosis Syndrome
Hypoglycemia Hypoglycemic Coma
Hypothyroidism Intestinal Obstruction

Graphical network of the top 20 diseases related to Decubitus Ulcer:



Diseases related to Decubitus Ulcer
Sources

Symptoms & Phenotypes for Decubitus Ulcer

About this section

UMLS symptoms related to Decubitus Ulcer:


pruritus, exanthema
Sources

Drugs & Therapeutics for Decubitus Ulcer

About this section

PubMedHealth treatment related to Decubitus Ulcer: 63

As much pressure as possible should be taken off of the pressure ulcer. The most important thing is to stop sitting or lying on the wound. Special positioning aids, special soft mattresses, and regular repositioning and movement help to relieve the pressure.Sterile wound dressings are usually used to protect the wound and help it to heal. If necessary, the wound is also regularly cleaned and dead tissue removed. The most appropriate treatment will depend on the type and severity of the pressure ulcer.

Drugs for Decubitus Ulcer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 268)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
acetic acid Approved Phase 4 64-19-7 176
2
Nitric Oxide Approved Phase 4,Phase 1,Phase 2,Not Applicable 10102-43-9 145068
3
Benzocaine Approved, Investigational Phase 4,Phase 1,Not Applicable 94-09-7, 1994-09-7 2337
4 tannic acid Approved Phase 4,Phase 1,Not Applicable
5
Bupivacaine Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 2180-92-9, 38396-39-3 2474
6
Lidocaine Approved, Vet_approved Phase 4,Not Applicable 137-58-6 3676
7
Racepinephrine Approved Phase 4,Phase 2,Phase 3,Not Applicable 329-65-7 838
8
Epinephrine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 51-43-4 5816
9
Petrolatum Approved, Investigational Phase 4,Not Applicable 8009-03-8
10
Midazolam Approved, Illicit Phase 4,Phase 3,Phase 2,Not Applicable 59467-70-8 4192
11
Sufentanil Approved, Investigational Phase 4 56030-54-7 41693
12
Ropivacaine Approved Phase 4,Not Applicable 84057-95-4 175805 71273
13
Sevoflurane Approved, Vet_approved Phase 4,Phase 2,Not Applicable 28523-86-6 5206
14
Propofol Approved, Investigational, Vet_approved Phase 4,Not Applicable 2078-54-8 4943
15
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 437-38-7 3345
16
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
17
Mepivacaine Approved, Vet_approved Phase 4 96-88-8 4062
18
Prilocaine Approved Phase 4,Not Applicable 721-50-6 4906
19
Titanium dioxide Approved Phase 4 13463-67-7
20
Zinc Approved, Investigational Phase 4,Phase 1,Phase 2,Not Applicable 7440-66-6
21
Linagliptin Approved Phase 4 668270-12-0 10096344
22
Insulin Glargine Approved Phase 4 160337-95-1
23
Metformin Approved Phase 4 657-24-9 14219 4091
24
Morphine Approved, Investigational Phase 4,Phase 1,Phase 2,Not Applicable 57-27-2 5288826
25
Alginic acid Approved, Investigational Phase 4,Phase 3,Not Applicable 9005-32-7
26
Ketamine Approved, Vet_approved Phase 4,Phase 3 6740-88-1 3821
27
Ketorolac Approved Phase 4 66635-83-4, 74103-06-3 3826
28
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
29
Guaifenesin Approved, Investigational, Vet_approved Phase 4 93-14-1 3516
30
Hydrocodone Approved, Illicit, Investigational Phase 4 125-29-1 5284569
31
Hydromorphone Approved, Illicit Phase 4,Not Applicable 466-99-9 5284570
32
Ibuprofen Approved Phase 4 15687-27-1 3672
33
Acetaminophen Approved Phase 4,Not Applicable 103-90-2 1983
34
Phenylephrine Approved Phase 4 59-42-7 6041
35
Oxymetazoline Approved, Investigational Phase 4 1491-59-4 4636
36
Ephedrine Approved Phase 4 299-42-3 9294
37
Norepinephrine Approved Phase 4 51-41-2 439260
38
Pseudoephedrine Approved Phase 4 90-82-4 7028
39
Tramadol Approved, Investigational Phase 4,Not Applicable 27203-92-5 33741
40
Rotigotine Approved Phase 4 99755-59-6, 92206-54-7 57537
41
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
42
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 4 7487-88-9 24083
43
Thrombin Approved, Investigational Phase 4,Not Applicable
44
St. John's Wort Approved, Investigational, Nutraceutical Phase 4 84082-80-4
45
Vitamin C Approved, Nutraceutical Phase 4,Not Applicable 50-81-7 5785 54670067
46
Synephrine Experimental Phase 4 1994-07-5, 94-07-5 7172
47 Olive Phase 4
48
Retinol acetate Phase 4 127-47-9 10245972
49 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
50 Analgesics, Opioid Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable

Interventional clinical trials:

(show top 50) (show all 564)
# Name Status NCT ID Phase Drugs
1 Olive Oil's Cream Effectiveness in Prevention of Pressure Ulcers in Immobilized Patients in Primary Care Unknown status NCT01595347 Phase 4 Hyper-oxigenated fatty acid
2 Efficacy of Quantum NPWT With Simultaneous Irrigation on Reduction of Wound Volume in Stage III/IV Pressure Ulcers. Unknown status NCT01734109 Phase 4
3 Clinical Evaluation of the SNaP Wound Care System Unknown status NCT01113658 Phase 4
4 Functional Electrical Stimulation-Assisted Walking: Reduction of Secondary Complications Due to Spinal Cord Injury Unknown status NCT00201968 Phase 4
5 Negative Pressure Wound Therapy With the Engenexâ„¢-Pump and Bio-Domeâ„¢ Dressing, an Evaluation Unknown status NCT01107821 Phase 4
6 Wound Management for Sacral Pressure Ulcers With Necrotic Tissue Completed NCT02224638 Phase 4
7 Pressure Ulcer Healing With Microcyn Completed NCT02001558 Phase 4 Microcyn
8 Effect of Prolonged Decubitus on Nitric Oxide Concentration in Chronic Obstructive Pulmonary Disease Completed NCT01555593 Phase 4
9 Prevention of Pressure Ulcers in Patients Under Non-Invasive Mechanical Ventilation Completed NCT02526862 Phase 4
10 Radiation Exposure During Endoscopic Retrograde Cholangiopancreatography Between Prone and Left Lateral Decubitus Completed NCT01599351 Phase 4
11 Determination of the 90% Effective Dose of a Sufentanil Bolus in Analgesia During Lateral Decubitus of Mechanically Ventilated Patients Completed NCT01356732 Phase 4 Sufentanil
12 A Multi-centre Evaluation of the Performance of Window Dressings on Subjects With High Risk Pressure Ulceration Completed NCT01438541 Phase 4
13 Study Comparing VERSAJET With Conventional Surgical Procedures in the Removal of Unhealthy Tissue From Lower Limb Ulcers Completed NCT00521027 Phase 4
14 The Effect of Combined General/Epidural Anesthesia Versus General Anesthesia on Diaphragmatic Function Completed NCT01547416 Phase 4 epidural 250mL of 0.2% ropivacaine and 2 μg/mL of fentanyl, 5 mL/hr continuous infusion and 0.5 mL bolus dose;no epidural drug administered
15 Evaluating the Efficacy of an Absorbent Foam Dressing Containing Silver (Mepilex Ag) Versus the Same Dressing Without Silver Used on Subjects With Venous Leg Ulcers or Mixed Ulcers Completed NCT01036438 Phase 4
16 Femoral Blockade and Low-dose Spinal Anesthesia in Outpatient Knee Arthroscopy Completed NCT02322372 Phase 4 Femoral blockade;Intrathecal anesthesia
17 Effects of Deep Neuromuscular Blockade on Intraoperative Respiratory Mechanics Completed NCT02185339 Phase 4 Rocuronium;Rocuronium
18 Spinal Anesthesia Versus Combined Sciatic-femoral Nerve Block for Outpatient Knee Arthroscopy Completed NCT02384915 Phase 4 prilocaine;mepivacaine
19 Surgical Approach Affect on Post-operative Analgesic Requirement Following Laparoscopic Nephrectomy Completed NCT02622893 Phase 4 Transperitoneal laparoscopic nephrectomy;Retroperitoneal laparoscopic nephrectomy
20 Comparison of Outcomes Between the Use of Silverlon® Dressing and AQUACEL® AG Dressing Post Cardiac Device Implant Completed NCT02781779 Phase 4
21 Mesoglycan, Vascular Reactivity and Metabolic Syndrome Completed NCT02254850 Phase 4 Mesoglycan;Mesoglycan;Placebo;Placebo
22 ADA Linagliptin in Long Term Care Completed NCT02061969 Phase 4 linagliptin;insulin glargine
23 Ketamine and Refractory Painful Care in a Palliative Unit Recruiting NCT02587130 Phase 4 Ketamine
24 The 90% Effective Dose of Nalbuphine in Mechanical Ventilated Patients in the ICU Recruiting NCT03786887 Phase 4 Nalbuphine
25 Interest in the Use of Dressings With Honey for Wound Healing After Excision of Pilonidal Cyst Recruiting NCT02485860 Phase 4
26 US-guided SAPB for Rib Fractures in the ED Recruiting NCT03619785 Phase 4 Bupivacaine;Fentanyl, morphine, hydromorphone, hydrocodone, acetaminophen, ketorolac, gabapentin, ketamine, ibuprofen
27 Fibrinolytic Therapy Versus Medical Thoracoscopy Recruiting NCT03213834 Phase 4 tPA;DNase
28 Vasoactive Drugs in Intensive Care Unit Recruiting NCT02118467 Phase 4 Norepinephrine;Epinephrine;Phenylephrine;Vasopressin
29 Rotigotine Effect on Nocturnal Hypokinesia Compares to Placebo Control: A Quantitative Assessment by Wearable Sensors Active, not recruiting NCT03098368 Phase 4 Rotigotine;Placebo
30 ESP Block in Pediatric Patients for Postoperative Analgesia Not yet recruiting NCT03627897 Phase 4 Regional Anesthetics;Saline
31 The Use of Intranasal Calcitonin to Improve Pain and Activity in Elderly Pelvic Ring Injuries Not yet recruiting NCT03812991 Phase 4 Miacalcin Calcitonin Salmon Nasal Spray
32 Magnesium Sulfate as an Adjuvant to Caudal Bupivacaine in Lower Abdominal Surgeries in Paediatrics. Not yet recruiting NCT03322878 Phase 4 Magnesium SO4
33 Lumbar Plexus vs Quadratus Lumborum Block in Post-operative Pain Following Total Hip Replacement Not yet recruiting NCT03801265 Phase 4 Ropivacaine injection
34 Does the Preoperative Midazolam Dose Affect Postoperative Pain? Not yet recruiting NCT03534895 Phase 4 Midazolam Injectable Solution;Postoperative analgesia;Rescue analgesia;Wound infiltration;Analgesia at home
35 Study of SANTYL® vs Hydrogel (SoloSite®) for Pressure Ulcers Terminated NCT02718625 Phase 4
36 Negative Pressure Wound Therapy for the Treatment of Chronic Pressure Wounds Terminated NCT00691821 Phase 4
37 Is Regional Anesthesia of the Hip Preferable Over Traditional Analgesia in the Acute Stage of the Management of Patients With a Fracture of the Hip Terminated NCT01593319 Phase 4 Ropivacaine;Natrium chloride
38 Manuka Honey for Wound Care Terminated NCT02259491 Phase 4 Manuka Honey Dressing
39 Leptospermum Scoparium Honey and Wound Care for Pressure Ulcers Withdrawn NCT02689310 Phase 4
40 A Prospective, Randomized, Controlled, Multi-Center, Study Evaluating AutoloGel Therapy for Complete Closure of Wagner Grade 1-4 Diabetic Foot Ulcers, Venous Leg Ulcers and Stage II-IV Pressure Ulcers Withdrawn NCT02248077 Phase 4
41 Use of Santyl Within an Accountable Care Organization Withdrawn NCT02716519 Phase 4
42 PEMF Effects on Pain After Abdominal Body Contouring Withdrawn NCT01762423 Phase 4
43 A Comparison of OASIS Wound Matrix With Approved Dressings for Skin Graft Donor Sites Withdrawn NCT02994589 Phase 4
44 Evaluation of White Sweet Potato Tube Feeding Formula on Type 2 Diabetic Residents in Long-term Care Institutions Unknown status NCT02711839 Phase 2, Phase 3
45 Liposomal Bupivacaine for Pain Control Following Thoracic Surgery. Unknown status NCT03036085 Phase 2, Phase 3 Liposomal bupivacaine;Bupivacaine;Epinephrine;Normal saline
46 Clinical Value of Noninvasive Intracranial Pressure Measurement Unknown status NCT02130219 Phase 2, Phase 3
47 Hip Fractures Treated With Uncemented Arthroplasties Unknown status NCT01798472 Phase 2, Phase 3
48 Pressure Ulcer Prevention Study in SCI Completed NCT01999816 Phase 3
49 Pressure Ulcer Prevention: Turning for Ulcer Reduction Completed NCT00665535 Phase 3
50 Pressure Ulcer Prevention in Ventilated Patients Using Two Repositioning Regimens Completed NCT00847665 Phase 3

Search NIH Clinical Center for Decubitus Ulcer

Cochrane evidence based reviews: pressure ulcer

Sources

Genetic Tests for Decubitus Ulcer

About this section
Sources

Anatomical Context for Decubitus Ulcer

About this section

MalaCards organs/tissues related to Decubitus Ulcer:

41
Skin, Spinal Cord, Bone, Testes, Colon, Brain, Bone Marrow
Sources

Publications for Decubitus Ulcer

About this section

Articles related to Decubitus Ulcer:

(show top 50) (show all 1138)
# Title Authors Year
1
Effect of Intensive Care Unit Nurses' Empowerment Program on Ability in Visual Differential Diagnosis of Pressure Ulcer Classification. ( 30507669 )
2019
2
Atypical Pressure Ulcer as Cellulitis Mimic. ( 29992424 )
2018
3
Fourier's gangrene associated with a decubitus ulcer. ( 29942775 )
2018
4
Decubitus Ulcer Development: An Investigation on Its Effect and Evidence in Home Care Patients. ( 30410266 )
2018
5
Effects of Derinat on ischemia-reperfusion-induced pressure ulcer mouse model. ( 30360946 )
2018
6
Melanoma arising in a chronic pressure ulcer. ( 30392193 )
2018
7
Sciatic neuropathy caused by a pressure ulcer: A case report. ( 30200159 )
2018
8
Pressure ulcer-related pelvic osteomyelitis: evaluation of a two-stage surgical strategy (debridement, negative pressure therapy and flap coverage) with prolonged antimicrobial therapy. ( 29636030 )
2018
9
Risk factors of pelvic pressure ulcer recurrence after primary skin flap surgery in people with spinal cord injury. ( 30273680 )
2018
10
Management of established pressure ulcer infections in spinal cord injury patients. ( 29937316 )
2018
11
Patient-controlled Analgesia and Postoperative Pressure Ulcer: A Meta-analysis of Observational Studies. ( 30372416 )
2018
12
Ingestion of bioactive collagen hydrolysates enhanced pressure ulcer healing in a randomized double-blind placebo-controlled clinical study. ( 30061579 )
2018
13
Pressure ulcer prevention using an alternating-pressure mattress overlay: the MATCARP project. ( 30086253 )
2018
14
Topical pentoxifylline for pressure ulcer treatment: a randomised, double-blind, placebo-controlled clinical trial. ( 30086256 )
2018
15
Perioperative factors and pressure ulcer development in postoperative ICU patients: a retrospective review. ( 30086257 )
2018
16
Assessing Pressure Injury Knowledge Using the Pieper-Zulkowski Pressure Ulcer Knowledge Test. ( 30134276 )
2018
17
Community care clinicians' experiences and perceptions of Waterlow pressure ulcer risk assessment. ( 30150130 )
2018
18
Cultural adaptation of the Pieper-Zulkowski Pressure Ulcer Knowledge Test for use in Brazil. ( 30156686 )
2018
19
High Voltage Monophasic Pulsed Current (HVMPC) for stage II-IV pressure ulcer healing. A systematic review and meta-analysis. ( 30177421 )
2018
20
Wound, pressure ulcer and burn guidelines - 2: Guidelines for the diagnosis and treatment of pressure ulcers, second edition. ( 30194884 )
2018
21
Feasibility of sub-dermal soft tissue deformation assessment using B-mode ultrasound for pressure ulcer prevention. ( 30195464 )
2018
22
Microclimate: A critical review in the context of pressure ulcer prevention. ( 30199821 )
2018
23
Relationship between pressure ulcer risk based on Norton Scale and on the "Eating/Drinking" need assessment. ( 30221444 )
2018
24
A prediction tool for hospital-acquired pressure ulcers among surgical patients: Surgical pressure ulcer risk score. ( 30289624 )
2018
25
Sequential Organ Failure Assessment (SOFA) to Predict Pressure Ulcer Risk in Intensive Care Patients: A Retrospective Cohort Study. ( 30312156 )
2018
26
Predictors of superficial and severe hospital-acquired pressure injuries: A cross-sectional study using the international pressure ulcer prevalenceâ„¢ survey. ( 30339955 )
2018
27
Evaluating the development and validation of empirically-derived prognostic models for pressure ulcer risk assessment: A systematic review. ( 30352322 )
2018
28
Primary repair of a massive pressure ulcer on the hip: report of one case. ( 30370288 )
2018
29
Success In Hospital-Acquired Pressure Ulcer Prevention: A Tale In Two Data Sets. ( 30395514 )
2018
30
Independent risk factors for pressure ulcer development in a high-risk nursing home population receiving evidence-based pressure ulcer prevention: Results from a study in 26 nursing homes in Belgium. ( 30412652 )
2018
31
A propeller SGAP flap raised from a previous gluteus maximus myocutaneous flap to reconstruct a recurrent type IV sacral pressure ulcer. ( 30462854 )
2018
32
Knowledge and attitudes of nurses in a major public hospital in Cyprus towards pressure ulcer prevention. ( 30466893 )
2018
33
Prevalence and risk factors of pressure ulcer in hospitalized adult patients; a single center study from Ethiopia. ( 30497485 )
2018
34
Pressure Ulcer in Intensive Care Units: a case-control study. ( 30517408 )
2018
35
Pressure ulcer definitions and core curricula-how does this affect wound care and the older patient? ( 30521358 )
2018
36
The Impact of Stress on Pressure Ulcer Wound Healing Process and on the Psychophysiological Environment of the Individual Suffering from them. ( 30524170 )
2018
37
A patient-reported pressure ulcer health-related quality of life instrument for use in prevention trials (PU-QOL-P): psychometric evaluation. ( 30526657 )
2018
38
Nurses' knowledge on pressure injury prevention: a systematic review and meta-analysis based on the Pressure Ulcer Knowledge Assessment Tool. ( 30538522 )
2018
39
Incisional negative pressure therapy reduces complications and costs in pressure ulcer reconstruction. ( 30548531 )
2018
40
The relationship between pressure ulcer risk assessment and preventative interventions: a systematic review. ( 30557105 )
2018
41
Personalized modeling for real-time pressure ulcer prevention in sitting posture. ( 28637592 )
2018
42
Standard laboratory tests are recommended as supplements to the Braden scale for pressure ulcer risk. ( 28639305 )
2018
43
The prevalence and specific characteristics of hospitalised pressure ulcer patients: A multicentre cross-sectional study. ( 28815825 )
2018
44
Clinical evaluation of a new pressure ulcer risk assessment instrument, the Pressure Ulcer Risk Primary or Secondary Evaluation Tool (PURPOSE T). ( 28833356 )
2018
45
Predictors of pressure ulcer incidence following traumatic spinal cord injury: a secondary analysis of a prospective longitudinal study. ( 28895575 )
2018
46
Prevalence of pressure ulcer and associated risk factors in middle- and older-aged medical inpatients in Norway. ( 28960642 )
2018
47
Nutritional blood parameters and nutritional risk screening in patients with spinal cord injury and deep pressure ulcer-a retrospective chart analysis. ( 29057992 )
2018
48
Development and validation of the experimental wound assessment tool (EWAT) for pressure ulcer in laboratory animals. ( 29100964 )
2018
49
Measuring the quality of pressure ulcer prevention: A systematic mapping review of quality indicators. ( 29178544 )
2018
50
Laser photobiomodulation in pressure ulcer healing of human diabetic patients: gene expression analysis of inflammatory biochemical markers. ( 29181642 )
2018
Sources

Variations for Decubitus Ulcer

About this section
Sources

Expression for Decubitus Ulcer

About this section
Search GEO for disease gene expression data for Decubitus Ulcer.
Sources

Pathways for Decubitus Ulcer

About this section

Pathways related to Decubitus Ulcer according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
FOXA2 and FOXA3 transcription factor networks 1
10.27 ALB TTR
Sources

GO Terms for Decubitus Ulcer

About this section
Sources

Sources for Decubitus Ulcer

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....